Skip to main content
. Author manuscript; available in PMC: 2024 May 1.
Published in final edited form as: Ophthalmology. 2022 Dec 12;130(5):533–541. doi: 10.1016/j.ophtha.2022.12.008

Table 1.

Participant characteristics

Participant Characteristics Excluded Included

No. of participants
  N 222 511
Protocol, N (%)
  AC 59 (27%) 211 (41%)
  AE 51 (23%) 84 (16%)
  W 112 (50%) 216 (42%)
Age, years
  Mean (SD) 59 (11) 59 (10)
  Median (IQR) 59 (52, 67) 59 (53, 65)
Sex, N (%)
  Female 94 (42%) 228 (45%)
  Male 128 (58%) 283 (55%)
Race/Ethnicity, N (%)
  White 109 (50%) 296 (58%)
  Hispanic or Latino 64 (29%) 118 (23%)
  Black/African American 39 (18%) 73 (14%)
  Other 8 (4%) 20 (4%)
Diabetes type, N (%)
  Type 1 20 (9%) 36 (7%)
  Type 2 202 (91%) 475 (93%)
Duration of diabetes, years
  Mean (SD) 17.4 (10.3) 16.7 (10.3)
  Median (IQR) 16.6 (10.2, 22.9) 15.8 (9.4, 22.6)
Insulin used, N (%)
  No 81 (36%) 167 (33%)
  Yes 141 (64%) 344 (67%)
Hemoglobin A1c, %
  Mean (SD) 8.4 (1.8) 8.5 (2.0)
  Median (IQR) 8.0 (7.2, 9.4) 8.1 (7.1, 9.5)

N missing: Race/Ethnicity (2 excluded and 4 included); Hemoglobin A1c (18 excluded and 17 included).